Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Heron Therapeutics (HRTX) Long-Term Debt Issuances (2021 - 2025)

Heron Therapeutics (HRTX) has disclosed Long-Term Debt Issuances for 3 consecutive years, with -$3.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$3.4 million, compared with a TTM value of -$3.4 million through Dec 2025, changed N/A, and an annual FY2025 reading of $105.4 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was -$3.4 million for Q4 2025 at Heron Therapeutics, down from -$19000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at -$19000.0 in Q3 2021 and bottomed at -$3.4 million in Q4 2025.